earnings
confidence high
sentiment negative
materiality 0.60
Greenbrook TMS Q1 revenue down 7% to $18.0M; net loss widens 36% to $14.5M
Greenbrook TMS Inc.
2024-Q1 EPS reported
-$0.32
revenue$5,563,038
- Revenue $18.0M (-7% YoY); regional operating loss $2.5M (+401%).
- Net loss $14.5M (+36% YoY); diluted EPS -$0.32 vs -$0.34.
- 130 active treatment centers (down from 162 YoY) due to restructuring plan.
- Spravato rollout at 84 centers; medication management at 9; talk therapy in FL and MO.
- Change Healthcare ransomware impacted billing/collections in Q1.